Medical robotics

Exoskeleton Market Research Report by Type, by Technology, by Product, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19

Retrieved on: 
Wednesday, July 29, 2020

Based on End User, the Exoskeleton Market studied across Hospitals, Manufacturing & Construction, Military & Defense, Rehabilitation Center, and Sport & Fitness.

Key Points: 
  • Based on End User, the Exoskeleton Market studied across Hospitals, Manufacturing & Construction, Military & Defense, Rehabilitation Center, and Sport & Fitness.
  • What are the inhibiting factors and impact of COVID-19 shaping the Global Exoskeleton Market during the forecast period?
  • Which are the products/segments/applications/areas to invest in over the forecast period in the Global Exoskeleton Market?
  • What are the modes and strategic moves considered suitable for entering the Global Exoskeleton Market?

Army Distaff Foundation-Knollwood is First Life Plan Community to Adopt Ekso Bionics’ Exoskeleton Device for Rehabilitation Following Successful Trial

Retrieved on: 
Thursday, July 9, 2020

As part of its comprehensive fall prevention program, ADF has invested in and implemented new technology and innovation like the EksoGT exoskeleton device.

Key Points: 
  • As part of its comprehensive fall prevention program, ADF has invested in and implemented new technology and innovation like the EksoGT exoskeleton device.
  • Through the program, ADF began trialing the use of EksoGT for rehabilitation with older adults at Knollwood in February 2018.
  • Thirty people completed the EksoGT therapy, which has improved gait, balance, strength and mobility, contributing to fewer falls, according to ADF.
  • The adoption of the EksoGT robotic exoskeleton was a natural choice for providing technology-enhanced health care in our community.

ReWalk Announces Publication of ReStore Powered Exo-Suit Clinical Study Results

Retrieved on: 
Monday, June 22, 2020

The study examined patient safety and explored functional walking outcomes in stroke survivors who completed a series of gait training sessions with the ReStore device.

Key Points: 
  • The study examined patient safety and explored functional walking outcomes in stroke survivors who completed a series of gait training sessions with the ReStore device.
  • The findings of the study were published in the June issue of the Journal of NeuroEngineering and Rehabilitation , and were the result of investigation by five leadingU.S.
  • As an active assistive device, the ReStore soft robotic exo-suit offers new opportunities to retrain walking after stroke."
  • "We are thrilled to see the results from the ReStore clinical trial being published in a joint paper authored by the primary investigators from all five of our highly regarded study sites," said Kathleen O'Donnell, Director of Product Management and Strategy at ReWalk Robotics.

Ekso Bionics Announces Closing of $7.89 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Retrieved on: 
Wednesday, June 10, 2020

The Company intends to use the net proceeds from the offering for working capital and general corporate purposes.

Key Points: 
  • The Company intends to use the net proceeds from the offering for working capital and general corporate purposes.
  • Ekso Bionics is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance, and mobility across medical and industrial applications.
  • The Company is headquartered in the San Francisco Bay Area and is listed on the Nasdaq Capital Market under the symbol EKSO.
  • To learn more about Ekso Bionics please visit the Companys website at www.eksobionics.com or refer to the Companys Twitter page at @EksoBionics.

Global Medical Robotics Market: Impact of COVID-19, Trends, Developments and Key Players Analysis (2020-2025) - ResearchAndMarkets.com

Retrieved on: 
Wednesday, June 10, 2020

The "Global Medical Robotics Market (By Segment - Surgical Robotics, Rehabilitation Robotics, Hospital and Pharmacy Robotics, By Application & Region), Key Players Analysis, Trends, Key Industry Developments - Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Medical Robotics Market (By Segment - Surgical Robotics, Rehabilitation Robotics, Hospital and Pharmacy Robotics, By Application & Region), Key Players Analysis, Trends, Key Industry Developments - Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
  • The Global Medical Robotics Market is expected to surpass US$ 16 Billion by 2025.
  • It is predicted that the Hospitals and pharmacy robots will contribute around 12% share to the global medical robotics market by 2025.
  • It is predicted that the Latin America will account for around 4% share of the global medical robotics market by 2025.

Ekso Bionics® Named “Best Healthcare Robotics Company” in 2020 MedTech Breakthrough Awards Program

Retrieved on: 
Wednesday, June 3, 2020

RICHMOND, Calif., June 03, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the Company) , an industry leader in exoskeleton technology for medical and industrial use,today announced that MedTech Breakthrough , an independent market intelligence organization that recognizes the top companies, technologies, and products in the global health and medical technology market, has selected Ekso Bionics as the winner of its Best Healthcare Robotics Company award in the fourth annual MedTech Breakthrough Awards program.

Key Points: 
  • RICHMOND, Calif., June 03, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the Company) , an industry leader in exoskeleton technology for medical and industrial use,today announced that MedTech Breakthrough , an independent market intelligence organization that recognizes the top companies, technologies, and products in the global health and medical technology market, has selected Ekso Bionics as the winner of its Best Healthcare Robotics Company award in the fourth annual MedTech Breakthrough Awards program.
  • Ekso Bionics designed EksoNR with new features to help physical therapists and patients get more out of rehabilitation sessions.
  • We are proud to receive recognition as the Best Healthcare Robotics Company from MedTech Breakthrough.
  • The continuing innovation at Ekso Bionics is an impressive series of technology breakthroughs and we are thrilled to recognize the entire Ekso team as our Best Healthcare Robotics Company award winner.

The Global Medical Robotics Market is expected to surpass US$ 16 Billion by 2025

Retrieved on: 
Tuesday, June 2, 2020

NEW YORK, June 2, 2020 /PRNewswire/ --The Global Medical Robotics Market is expected to surpass US$ 16 Billion by 2025.

Key Points: 
  • NEW YORK, June 2, 2020 /PRNewswire/ --The Global Medical Robotics Market is expected to surpass US$ 16 Billion by 2025.
  • It is predicted that the Hospitals and pharmacy robots will contribute around 12% share to the global medical robotics market by 2025.
  • It is predicted that the Latin America will account for around 4% share of the global medical robotics market by 2025.
  • The report titled "Global Medical Robotics Market (By Segment - Surgical Robotics, Rehabilitation Robotics, Hospital and Pharmacy Robotics, By Application & Region), Key Players Analysis, Trends, Key Industry Developments - Forecast to 2025" provides a comprehensive assessment of the fast-evolving, high-growth Medical Robotics Industry.

ReWalk Robotics Reports First Quarter 2020 Financial Results

Retrieved on: 
Thursday, May 28, 2020

ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.

Key Points: 
  • ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.
  • ReWalk is a registered trademark of ReWalk Robotics Ltd. in Israel and the United States.
  • ReStore is a registered trademark of ReWalk Robotics Ltd. in Europe and an allowed trademark in the United States.
  • ReWalk urges investors to review the reconciliation of the Companys non-GAAP financial measures to the comparable GAAP financial measures included below, and not to rely on any single financial measure to evaluate the Companys business.

ReWalk Robotics to Report First Quarter 2020 Financial Results on May 28, 2020

Retrieved on: 
Tuesday, May 26, 2020

ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.

Key Points: 
  • ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.
  • ReWalks mission is to fundamentally change the quality of life for individuals with lower limb disability through the creation and development of market leading robotic technologies.
  • Founded in 2001, ReWalk has headquarters in the U.S., Israel and Germany.
  • ReWalk is a registered trademark of ReWalk Robotics Ltd. in Israel and the Unites States.

Harmonic Bionics to Showcase New Upper Body Robotic Rehabilitation System, Harmony SHR, in Live Virtual Demos

Retrieved on: 
Monday, May 18, 2020

AUSTIN, Texas, May 18, 2020 /PRNewswire/ --Harmonic Bionics, Inc. announced today that they will be hosting live virtual demos of the company's new upper body robotic rehabilitation system, Harmony SHR.

Key Points: 
  • AUSTIN, Texas, May 18, 2020 /PRNewswire/ --Harmonic Bionics, Inc. announced today that they will be hosting live virtual demos of the company's new upper body robotic rehabilitation system, Harmony SHR.
  • When combined with Harmony SHR's Weight Support mode, this unique shoulder design may allow for earlier initiation of post-stroke therapy.
  • We believe the future of rehabilitation lies in technologies, like Harmony SHR, that increase access by facilitating more community-based therapy and home-based therapy."
  • Currently, virtual demonstrations will be held through June and Harmonic Bionics plans to begin scheduling in-person demonstrations of Harmony SHR in late summer.